On June 23, 2026, Clean Energy Fuels Corp. (the “Company”) announced that Bartolomeo A. Frabotta, the Company’s former Group Vice President, has been appointed as the Company’s Chief Operating Officer, effective as of June 23, 2026
effective July 1, 2026, Zachary D. Hornby will cease his role as President and Chief Executive Officer, and as a member of the board of directors of Boundless Bio.
effective July 1, 2026, Jessica Oien, Boundless Bio’s Chief Legal Officer and Corporate Secretary, was appointed to serve as Boundless Bio’s President and "principal executive officer," in addition to maintaining her current responsibilities as Chief Legal Officer and Corporate Secretary.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Jonathan Heller, Jonathan Kolatch, William A. Lamkin, Adam D. Portnoy and Irvin Schlussel (each, a “ New Trustee ”) were elected as members of the board of trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Jonathan Heller, Jonathan Kolatch, William A. Lamkin, Adam D. Portnoy and Irvin Schlussel (each, a “ New Trustee ”) were elected as members of the board of trustees of the Company.
Jonathan Heller, Jonathan Kolatch, William A. Lamkin, Adam D. Portnoy and Irvin Schlussel (each, a “ New Trustee ”) were elected as members of the board of trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Jonathan Heller, Jonathan Kolatch, William A. Lamkin, Adam D. Portnoy and Irvin Schlussel (each, a “ New Trustee ”) were elected as members of the board of trustees of the Company.
Jonathan Heller, Jonathan Kolatch, William A. Lamkin, Adam D. Portnoy and Irvin Schlussel (each, a “ New Trustee ”) were elected as members of the board of trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
On June 16, 2026, Fidelity Bank (the “ Bank ”) and its holding company FB Bancorp, Inc. (the “ Company ”) informed Mr. Randall L. Baker, Chief Operating Officer, that he would be separated from the Bank effective as of June 16, 2026.
On June 18, 2026, Jeffrey Howowitz gave notice that he will retire as Chief Compliance Officer of BitGo Holdings, Inc. (the “ Company ”), effective June 19, 2026.
Effective June 19, 2026, the Board of Directors (the Board) of Centene Corporation (the Company) increased the size of the Board from 9 to 10 and elected Lauren Tyler to the Board to fill the resulting vacancy
Will Mudd, who currently serves as Senior Vice President, Finance of the Company, has been appointed Senior Vice President and Chief Financial Officer of the Company, also effective as of July 1, 2026.
On June 22, 2026, Guardian Pharmacy Services, Inc. (the “Company”) announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026.
The Company also announced on June 22, 2026, that upon Mr. Forbes’s retirement, and also effective as of July 1, 2026, David Morris will transition from his current role as Executive Vice President and Chief Financial Officer of the Company to the role of Executive Vice President, Chief Operating Officer.
On June 16, 2026, the Company and Mr. Needham entered into a Retirement, Separation, Waiver and Release Agreement (the “Retirement Agreement”) in connection with Mr. Needham’s retirement from employment with the Company, effective June 20, 2026.
On June 17, 2026, the Board of Directors of TD SYNNEX Corporation (the “Company”) appointed Douglas Britt as a member of the Company’s Board of Directors (the “Board”) effective as of June 17, 2026, increasing the size of the Board from ten to eleven members.
On June 18, 2026, the Board appointed Thomas Schiller as a Class III director, upon the recommendation of its Nominating and Corporate Governance Committee with such appointment effective as of the Effective Date
On June 15, 2026, Dr. Ichiro Aoki notified the Board of Directors (the “Board”) of indie Semiconductor, Inc. (the “Company”) of his intent to resign as a member of the Board and as President of the Company, effective June 29, 2026 (the “Effective Date”), as part of a phased retirement plan.
On June 17, 2026, Mary A. Tidlund notified the registrant of her decision to resign as a director of the registrant. Her resignation from the board of directors of the registrant will be effective on June 30, 2026 and did not result from any disagreement with the registrant.
Craig Sasser will transition from his current role as the Company’s Regional Vice President – Atlantic Region to the role of Company Chief Operating Officer, effective July 1, 2026.
On June 22, 2026, the Board of Directors (the “Board”) of Dyne Therapeutics, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Barry E. Greene as a Class I director to serve on the Board until the Company’s 2027 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.
Panos Kozanian, Executive Vice President of Product Engineering of the Company, have mutually agreed to begin a transition with respect to Mr. Kozanian’s responsibilities, effective June 29, 2026.
Departed
Matt Bilunas
Senior Executive Vice President, Chief Financial Officer and Enterprise Strategy
Best Buy Co., Inc. (the “Company” or “registrant”) announced that Matt Bilunas, the Company’s Senior Executive Vice President, Chief Financial Officer and Enterprise Strategy, will depart the Company effective July 31, 2026.
On June 22, 2026, Arvinas, Inc., a Delaware corporation (the “Company”), and Noah Berkowitz, M.D., Ph.D., the Company’s chief medical officer, agreed that Dr. Berkowitz would depart from his employment with the Company, effective July 3, 2026 (the “Departure”).
On June 22, 2026, PagerDuty, Inc. (the “Company”) announced the appointment of Eric Prengel as the Company’s Chief Financial Officer (“CFO”), effective June 22, 2026 (the “Appointment Date”).
Mr. Khemka succeeds Trent Thrash, who has served as Interim Chief Financial Officer (Principal Financial Officer) since March 2026 and will continue in his role as Senior Vice President of Corporate Development, Investor Relations and Treasury.
On June 22, 2026, NVE Corporation (the “Company”) announced that Daniel A. Baker, Ph.D., age 68, will retire as President and Chief Executive Officer effective at the Company’s Annual Shareholders’ meeting on August 6, 2026.
Current Chairman Terence W. Glarner, age 83, was nominated to remain on the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.